Anti-IL8/ CXCL8/ GCP-1 functional antibody
Anti-IL8/ CXCL8/ GCP-1 functional antibody for cell culture, ELISA & in-vivo assay
Go to IL8/CXCL8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T22658-Ab-1/ GM-Tg-hg-T22658-Ab-2 | Anti-Human IL8/CXCL8 monoclonal antibody | Human |
GM-Tg-rg-T22658-Ab-1/ GM-Tg-rg-T22658-Ab-2 | Anti-Rat IL8/CXCL8 monoclonal antibody | Rat |
GM-Tg-mg-T22658-Ab-1/ GM-Tg-mg-T22658-Ab-2 | Anti-Mouse IL8/CXCL8 monoclonal antibody | Mouse |
GM-Tg-cynog-T22658-Ab-1/ GM-Tg-cynog-T22658-Ab-2 | Anti-Cynomolgus/ Rhesus macaque IL8/CXCL8 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T22658-Ab-1/ GM-Tg-felg-T22658-Ab-2 | Anti-Feline IL8/CXCL8 monoclonal antibody | Feline |
GM-Tg-cang-T22658-Ab-1/ GM-Tg-cang-T22658-Ab-2 | Anti-Canine IL8/CXCL8 monoclonal antibody | Canine |
GM-Tg-bovg-T22658-Ab-1/ GM-Tg-bovg-T22658-Ab-2 | Anti-Bovine IL8/CXCL8 monoclonal antibody | Bovine |
GM-Tg-equg-T22658-Ab-1/ GM-Tg-equg-T22658-Ab-2 | Anti-Equine IL8/CXCL8 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T22658-Ab-1/ GM-Tg-hg-T22658-Ab-2; GM-Tg-rg-T22658-Ab-1/ GM-Tg-rg-T22658-Ab-2; GM-Tg-mg-T22658-Ab-1/ GM-Tg-mg-T22658-Ab-2; GM-Tg-cynog-T22658-Ab-1/ GM-Tg-cynog-T22658-Ab-2; GM-Tg-felg-T22658-Ab-1/ GM-Tg-felg-T22658-Ab-2; GM-Tg-cang-T22658-Ab-1/ GM-Tg-cang-T22658-Ab-2; GM-Tg-bovg-T22658-Ab-1/ GM-Tg-bovg-T22658-Ab-2; GM-Tg-equg-T22658-Ab-1/ GM-Tg-equg-T22658-Ab-2 |
Products Name | Anti-IL8/CXCL8 monoclonal antibody |
Format | mab |
Target Name | IL8 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody, Therapeutics Target antibody, Cytokine antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-IL8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-T22658-Ag-1 | Recombinant multi-species IL8/ CXCL8/ GCP-1 protein |
Cytokine | GM-Tg-g-T22658-Ag-1 | interleukin 8 (IL8) protein |
ORF Viral Vector | vGMAP000556 | Human IL8 Adenovirus particle |
ORF Viral Vector | vGMLV000447 | human CXCL8 Lentivirus particle |
ORF Viral Vector | pGMLV000447 | human CXCL8 Lentivirus plasmid |
ORF Viral Vector | pGMAP000556 | Human IL8 Adenovirus plasmid |
Target information
Target ID | GM-T22658 |
Target Name | IL8 |
Gene ID | 3576,613028,280828,100037400 |
Gene Symbol and Synonyms | CXCL8,GCP-1,GCP1,IL-8,IL8,LECT,LUCT,LYNAP,MDNCF,MONAP,NAF,NAP-1,NAP1,SCYB8 |
Uniprot Accession | P10145,P67813,P41324,P79255,O62812 |
Uniprot Entry Name | IL8_HUMAN,IL8_MACMU,IL8_CANLF,IL8_BOVIN,IL8_HORSE |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | Therapeutics Target, Immuno-oncology Target, Cytokine Target |
Disease | N/A |
Gene Ensembl | ENSG00000169429 |
Target Classification | Checkpoint-Immuno Oncology |
The target: IL8, gene name: CXCL8, also named as GCP-1, GCP1, IL8, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1. The protein encoded by this gene is a member of the CXC chemokine family and is a major mediator of the inflammatory response. The encoded protein is commonly referred to as interleukin-8 (IL-8). IL-8 is secreted by mononuclear macrophages, neutrophils, eosinophils, T lymphocytes, epithelial cells, and fibroblasts. It functions as a chemotactic factor by guiding the neutrophils to the site of infection. Bacterial and viral products rapidly induce IL-8 expression. IL-8 also participates with other cytokines in the proinflammatory signaling cascade and plays a role in systemic inflammatory response syndrome (SIRS). This gene is believed to play a role in the pathogenesis of the lower respiratory tract infection bronchiolitis, a common respiratory tract disease caused by the respiratory syncytial virus (RSV). The overproduction of this proinflammatory protein is thought to cause the lung inflammation associated with csytic fibrosis. This proinflammatory protein is also suspected of playing a role in coronary artery disease and endothelial dysfunction. This protein is also secreted by tumor cells and promotes tumor migration, invasion, angiogenesis and metastasis. This chemokine is also a potent angiogenic factor. The binding of IL-8 to one of its receptors (IL-8RB/CXCR2) increases the permeability of blood vessels and increasing levels of IL-8 are positively correlated with increased severity of multiple disease outcomes (eg, sepsis). This gene and other members of the CXC chemokine gene family form a gene cluster in a region of chromosome 4q. [provided by RefSeq, May 2020].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.